Insiders Halozyme Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-28 pm EDT			5-day change	1st Jan Change
43.08 ^USD	-1.69%		-4.20%	+16.56%

May. 22	Halozyme Therapeutics Insider Sold Shares Worth $905,480, According to a Recent SEC Filing	MT
May. 07	Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed	MT

Halozyme Therapeutics Insider Sold Shares Worth $905,480, According to a Recent SEC Filing	May. 22	MT
Halozyme Therapeutics, Inc. Announces the Election of Mahesh Krishnan, M.D. to its Board of Directors	Apr. 25	CI
Halozyme Therapeutics Insider Sold Shares Worth $768,390, According to a Recent SEC Filing	Apr. 18	MT
Halozyme Therapeutics Insider Sold Shares Worth $839,100, According to a Recent SEC Filing	Mar. 13	MT
Halozyme Therapeutics Insider Sold Shares Worth $720,000, According to a Recent SEC Filing	Jan. 18	MT
Halozyme Therapeutics Insider Sold Shares Worth $800,262, According to a Recent SEC Filing	Dec. 14	MT
Halozyme Therapeutics Insider Sold Shares Worth $788,670, According to a Recent SEC Filing	Nov. 16	MT
Halozyme Therapeutics Insider Sold Shares Worth $365,200, According to a Recent SEC Filing	23-10-18	MT
Insider Sell: Halozyme Therapeutics	23-08-31	MT
Insider Sell: Halozyme Therapeutics	23-08-23	MT
Insider Sell: Halozyme Therapeutics	23-08-15	MT
Insider Sell: Halozyme Therapeutics	23-07-27	MT
Halozyme Therapeutics, Inc. Announces Resignation of James M. Daly as A Member of the Board of Directors	23-02-23	CI
Insider Sell: Halozyme Therapeutics	23-02-17	MT
Insider Sell: Halozyme Therapeutics	23-02-10	MT
Halozyme Therapeutics Appoints Barbara Duncan to Its Board of Directors	23-02-06	CI
Insider Sell: Halozyme Therapeutics	23-01-19	MT
Insider Sell: Halozyme Therapeutics	22-12-16	MT
Insider Sell: Halozyme Therapeutics	22-12-07	MT
Halozyme Therapeutics, Inc. Appoints Moni Miyashita to Board of Directors	22-03-15	CI

No results for this search